Estrella Immunopharma (ESLA) Stock Chart & Stock Price History $1.29 +0.13 (+11.21%) (As of 02:56 PM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Estrella Immunopharma Stock Price Performance 5 Day Performance+24.04%1 Month Performance+77.69%3 Month Performance+17.27%6 Month Performance+40.22%Year-To-Date Performance+16.22%1 Year Performance-11.03% Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. ESLA Stock Chart for Tuesday, December, 3, 2024 ESLA Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/02/2024$1.14$1.16+2.20%$1.20$1.1441,070 shs$41.97 million11/29/2024$1.04$1.14+9.13%$1.18$1.0749,847 shs$41.06 million11/28/2024$1.04$1.04$1.09$1.0019,166 shs$37.63 million11/27/2024$1.01$1.04+2.97%$1.09$1.0019,166 shs$37.63 million11/26/2024$1.00$1.01+1.00%$1.05$0.9728,029 shs$36.54 million11/25/2024$0.91$1.00+9.89%$1.10$0.8954,230 shs$36.18 million Get the Latest News and Ratings for ESLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 11/22/2024$0.91$0.91+0.55%$0.99$0.9013,899 shs$32.92 million11/21/2024$0.92$0.91-1.68%$0.93$0.8922,262 shs$32.74 million11/20/2024$0.85$0.92+8.17%$0.99$0.8531,278 shs$33.30 million11/19/2024$0.85$0.85+0.59%$0.88$0.854,101 shs$30.79 million11/18/2024$0.89$0.85-4.94%$0.90$0.815,375 shs$30.61 million11/15/2024$0.84$0.89+5.95%$0.89$0.7515,269 shs$32.21 million11/14/2024$0.84$0.84$0.84$0.753,930 shs$30.40 million11/13/2024$0.80$0.84+5.40%$0.84$0.755,995 shs$30.40 million11/12/2024$0.76$0.80+4.66%$0.81$0.7410,010 shs$28.84 million11/11/2024$0.74$0.76+2.91%$0.80$0.7419,938 shs$27.56 million11/08/2024$0.80$0.74-7.62%$0.80$0.7034,627 shs$26.78 million11/07/2024$0.79$0.80+1.37%$0.83$0.7911,859 shs$28.99 million11/06/2024$0.85$0.79-7.04%$0.92$0.7020,336 shs$28.60 million11/05/2024$0.78$0.85+8.63%$0.92$0.802,992 shs$30.76 million11/04/2024$0.73$0.78+7.78%$0.87$0.7314,179 shs$28.32 million Related Companies Adverum Biotechnologies Stock Chart InflaRx Stock Chart Skye Bioscience Stock Chart Compugen Stock Chart Cardiff Oncology Stock Chart Protalix BioTherapeutics Stock Chart Cardiol Therapeutics Stock Chart Scilex Stock Chart Repare Therapeutics Stock Chart Innate Pharma Stock Chart Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLA) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.